2019 annual financial data

Lyell Immunopharma 2019 Financial results

Direct answer

Revenue was 657,000 USD.

Operating income was -102.09M USD and net income was -129.38M USD.
Operating cash flow was 39.47M USD.

Get free Lyell Immunopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
657,000 USD
Operating income
-102.09M USD
Net income
-129.38M USD
Operating cash flow
39.47M USD